{"id":"doxazosin-drug","safety":{"commonSideEffects":[{"rate":"10-15","effect":"Dizziness"},{"rate":"5-10","effect":"Fatigue"},{"rate":"5-10","effect":"Headache"},{"rate":"1-2","effect":"Syncope (first-dose effect)"},{"rate":"2-5","effect":"Palpitations"},{"rate":"2-5","effect":"Edema"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Doxazosin selectively inhibits alpha-1 adrenergic receptors on vascular smooth muscle and in the prostate. This blockade reduces peripheral vascular resistance, lowering blood pressure, and also relaxes smooth muscle in the bladder neck and prostate, improving urinary flow. The drug is used for both hypertension and benign prostatic hyperplasia.","oneSentence":"Doxazosin is an alpha-1 adrenergic receptor antagonist that blocks norepinephrine signaling in blood vessels and the prostate, causing vasodilation and smooth muscle relaxation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:44:58.729Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Benign prostatic hyperplasia with lower urinary tract symptoms"}]},"trialDetails":[{"nctId":"NCT04135846","phase":"PHASE2","title":"Alpha-1 Blockade for Alcohol Use Disorder (AUD)","status":"RECRUITING","sponsor":"Brown University","startDate":"2019-12-19","conditions":"Alcohol Use Disorder (AUD)","enrollment":184},{"nctId":"NCT01437046","phase":"EARLY_PHASE1","title":"Doxazosin an a1 Antagonist for Alcohol Dependence","status":"COMPLETED","sponsor":"Brown University","startDate":"2011-11-01","conditions":"Alcohol Dependence, Anxiety","enrollment":41},{"nctId":"NCT04991961","phase":"","title":"Effect of Anti-hypertensive Medications on the Diagnostic Accuracy in Primary Aldosteronism","status":"COMPLETED","sponsor":"Chongqing Medical University","startDate":"2020-09-15","conditions":"Hypertension, Primary Aldosteronism","enrollment":341},{"nctId":"NCT05360953","phase":"PHASE2","title":"Treating Nightmares in Posttraumatic Stress Disorder With Clonidine and Doxazosin","status":"SUSPENDED","sponsor":"Charite University, Berlin, Germany","startDate":"2022-06-17","conditions":"Posttraumatic Stress Disorder","enrollment":53},{"nctId":"NCT02901977","phase":"PHASE4","title":"Doxazosin and Ramipril in Hypertension","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2011-03","conditions":"Hypertension","enrollment":71},{"nctId":"NCT01379898","phase":"PHASE4","title":"Phenoxybenzamine Versus Doxazosin in PCC Patients","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2011-12","conditions":"Pheochromocytoma","enrollment":134},{"nctId":"NCT03339258","phase":"PHASE2","title":"A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD","status":"ACTIVE_NOT_RECRUITING","sponsor":"San Francisco Veterans Affairs Medical Center","startDate":"2018-04-15","conditions":"Stress Disorders, Post-Traumatic","enrollment":80},{"nctId":"NCT00006294","phase":"","title":"Genetics of Hypertension Associated Treatments (GenHAT)","status":"COMPLETED","sponsor":"Donna Arnett, 257-5678","startDate":"1999-09","conditions":"Cardiovascular Diseases, Heart Diseases, Hypertension","enrollment":37939},{"nctId":"NCT06282731","phase":"EARLY_PHASE1","title":"The Changes of Urine Growth Factors Level","status":"COMPLETED","sponsor":"En Chu Kong Hospital","startDate":"2013-05-31","conditions":"Benign Prostatic Hyperplasia","enrollment":74},{"nctId":"NCT06175663","phase":"","title":"Hyperintense: Midlife Hypertension and the Brain","status":"UNKNOWN","sponsor":"Radboud University Medical Center","startDate":"2021-07-06","conditions":"Hypertension, Small Vessel Cerebrovascular Disease","enrollment":130},{"nctId":"NCT01798992","phase":"PHASE4","title":"Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2000-09","conditions":"Idiopathic Dilated Cardiomyopathy","enrollment":56},{"nctId":"NCT03176693","phase":"PHASE3","title":"Preoperative Alpha Blockade for Pheochromocytoma","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2017-05-05","conditions":"Pheochromocytoma, Paraganglioma","enrollment":39},{"nctId":"NCT03398252","phase":"PHASE1","title":"Targeting Stress-Induced Alcohol Relapse Risk With Doxazosin XL","status":"WITHDRAWN","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2022-05-12","conditions":"Alcohol Use Disorder","enrollment":""},{"nctId":"NCT02308202","phase":"PHASE1","title":"DOXAZOSIN FOR PTSD","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2012-01","conditions":"PTSD","enrollment":30},{"nctId":"NCT02538744","phase":"PHASE1","title":"Complementary Combination Therapy for Cocaine Dependence","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2015-08","conditions":"Cocaine Dependence","enrollment":45},{"nctId":"NCT05094947","phase":"NA","title":"Intermittent Catheterization Versus Trial Without Catheter","status":"UNKNOWN","sponsor":"Moscow State University of Medicine and Dentistry","startDate":"2021-08-03","conditions":"Benign Prostatic Hyperplasia","enrollment":200},{"nctId":"NCT04557072","phase":"","title":"Selective Versus Nonselective Alpha-blockade Prior to Pheochromocytoma Resection - Systematic Review and Meta-analysis","status":"COMPLETED","sponsor":"Jagiellonian University","startDate":"2020-08-01","conditions":"Pheochromocytoma","enrollment":1344},{"nctId":"NCT02500602","phase":"PHASE2","title":"CAP: Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2016-06-01","conditions":"Posttraumatic Stress Disorder, Alcohol Use Disorders","enrollment":144},{"nctId":"NCT04467931","phase":"","title":"ACEI or ARB and COVID-19 Severity and Mortality in US Veterans","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-01-19","conditions":"Hypertension, COVID","enrollment":22213},{"nctId":"NCT03415581","phase":"PHASE2","title":"Evaluation of Doxazosin to Alter the Abuse of Oxycodone","status":"TERMINATED","sponsor":"New York State Psychiatric Institute","startDate":"2017-02-12","conditions":"Opioid-use Disorder","enrollment":13},{"nctId":"NCT02989493","phase":"PHASE2","title":"Testing Doxazosin to Treat Stress Mechanisms in Alcoholism","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2017-04-12","conditions":"Alcoholism","enrollment":61},{"nctId":"NCT00645034","phase":"PHASE2","title":"A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With Doxazosin","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2002-11","conditions":"Benign Prostatic Hyperplasia","enrollment":20},{"nctId":"NCT00646841","phase":"PHASE4","title":"Effects of Doxazosin Gastrointestinal Therapeutic System on Ambulatory Blood Pressure and Cardiovascular Risk Factors in Uncontrolled Hypertensive Patients","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-02","conditions":"Hypertension","enrollment":89},{"nctId":"NCT00648323","phase":"PHASE4","title":"Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-11","conditions":"Prostate","enrollment":80},{"nctId":"NCT01389609","phase":"PHASE1","title":"Bioequivalence Study of Doxazosin 4 Mg Orally-Disintegrating Tablet With Or Without Water To Doxazosin 4 Mg Japanese Marketed Immediate Release Tablet Under Fasted Condition","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-07","conditions":"Hypertension","enrollment":24},{"nctId":"NCT01003886","phase":"","title":"A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH)","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2009-05","conditions":"Prostatic Hyperplasia","enrollment":989},{"nctId":"NCT00535925","phase":"PHASE4","title":"Nephropathy In Type 2 Diabetes and Cardio-renal Events","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2005-10","conditions":"Diabetic Nephropathy","enrollment":850},{"nctId":"NCT04371757","phase":"NA","title":"Influence of the Autonomic Nervous System in Response to Exercise in Hypertensive Individuals","status":"UNKNOWN","sponsor":"Instituto de Cardiologia do Rio Grande do Sul","startDate":"2020-04-30","conditions":"Autonomic Nervous System, Hypertension","enrollment":39},{"nctId":"NCT01953432","phase":"PHASE2","title":"Pharmacogenetic Trial of Doxazosin for Treatment of Cocaine Abuse","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2014-04-01","conditions":"Cocaine Dependence","enrollment":43},{"nctId":"NCT00922506","phase":"PHASE4","title":"Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2009-05","conditions":"Overactive Bladder, Benign Prostatic Hyperplasia","enrollment":83},{"nctId":"NCT00880997","phase":"PHASE1","title":"The Efficacy of Doxazosin for Cocaine Users","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2009-09","conditions":"Cocaine Dependence","enrollment":35},{"nctId":"NCT01145183","phase":"PHASE2","title":"Pharmacogenetics of Doxazosin for Cocaine Dependence","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2010-03","conditions":"Cocaine Dependence","enrollment":96},{"nctId":"NCT01946035","phase":"PHASE4","title":"Alpha-Blockers in Allergic Rhinitis (MAN 01)","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2013-09","conditions":"Allergic Rhinitis","enrollment":17},{"nctId":"NCT01386177","phase":"PHASE1","title":"Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA)","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2011-07","conditions":"Mood Disorder, Substance-Related Disorders, Amphetamine-Related Disorders","enrollment":16},{"nctId":"NCT00021814","phase":"PHASE3","title":"Medical Therapy of Prostatic Symptoms","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"1995-12","conditions":"Prostatic Hyperplasia, Prostatic Hypertrophy, Benign","enrollment":3407},{"nctId":"NCT00741585","phase":"PHASE4","title":"Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment","status":"COMPLETED","sponsor":"University of Vigo","startDate":"2008-09-01","conditions":"Essential Hypertension, Cardiovascular Disease, Stroke","enrollment":21983},{"nctId":"NCT00004266","phase":"PHASE3","title":"Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"1993-08","conditions":"Diabetic Nephropathy","enrollment":160},{"nctId":"NCT01730846","phase":"PHASE2","title":"Does Doxazosin Attenuate Stress-induced Smoking and Improve Clinical Outcomes?","status":"COMPLETED","sponsor":"Yale University","startDate":"2013-02","conditions":"Smoking","enrollment":35},{"nctId":"NCT01323998","phase":"","title":"Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: Marketscan","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-04","conditions":"Prostatic Hyperplasia","enrollment":35032},{"nctId":"NCT03043612","phase":"NA","title":"Ureteral Stent Study","status":"COMPLETED","sponsor":"Cook Group Incorporated","startDate":"2015-06-10","conditions":"Urolithiasis","enrollment":56},{"nctId":"NCT01332435","phase":"","title":"Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-11","conditions":"Prostatic Hyperplasia","enrollment":6896},{"nctId":"NCT01332487","phase":"","title":"Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-08","conditions":"Prostatic Hyperplasia","enrollment":4068},{"nctId":"NCT01386983","phase":"","title":"Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-03","conditions":"Prostatic Hyperplasia","enrollment":332},{"nctId":"NCT01390870","phase":"","title":"Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-05","conditions":"Prostatic Hyperplasia","enrollment":400},{"nctId":"NCT01435954","phase":"","title":"Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-08","conditions":"Benign Prostatic Hyperplasia","enrollment":13551},{"nctId":"NCT01959022","phase":"PHASE4","title":"A Pilot Study to Assess the Effects of Doxazosin on Polysomnography in PTSD","status":"COMPLETED","sponsor":"San Francisco Veterans Affairs Medical Center","startDate":"2013-10","conditions":"Stress Disorders, Post-Traumatic","enrollment":15},{"nctId":"NCT02785393","phase":"PHASE1","title":"DOX as a Potential Treatment for Methamphetamine Dependence","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2011-03","conditions":"Substance-Related Disorders","enrollment":11},{"nctId":"NCT00000542","phase":"PHASE3","title":"Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1993-08","conditions":"Cardiovascular Diseases, Coronary Disease, Diabetes Mellitus","enrollment":""},{"nctId":"NCT02563405","phase":"PHASE2, PHASE3","title":"The Effects of Doxazosin and Nifedipine on Blood Pressure Variability and Uric Acid in Plasma in Hypertensive Patients","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Harbin Medical University","startDate":"2015-09","conditions":"Hypertension","enrollment":30},{"nctId":"NCT00000522","phase":"PHASE2","title":"Treatment of Mild Hypertension Study (TOMHS)","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"1985-08","conditions":"Cardiovascular Diseases, Heart Diseases, Hypertension","enrollment":""},{"nctId":"NCT01371851","phase":"PHASE1, PHASE2","title":"Doxazosin for Psychostimulant Dependence","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2011-06","conditions":"Methamphetamine or Cocaine Dependence","enrollment":22},{"nctId":"NCT02369081","phase":"PHASE4","title":"Optimum Treatment for Drug-Resistant Hypertension","status":"UNKNOWN","sponsor":"University of Cambridge","startDate":"2009-05","conditions":"Hypertension, Resistant to Conventional Therapy","enrollment":348},{"nctId":"NCT01819220","phase":"PHASE4","title":"Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic Syndrome","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2009-04","conditions":"Hypertension","enrollment":16},{"nctId":"NCT00141596","phase":"NA","title":"Extracellular Fluid in Resistant Hypertension","status":"TERMINATED","sponsor":"St George's, University of London","startDate":"2003-07","conditions":"Hypertension","enrollment":32},{"nctId":"NCT02266537","phase":"PHASE1","title":"Study to Assess the Influence of Three Different α-antagonists and Placebo on the Extent of Weekly Phenylephrine-induced Mydriasis at Three Different Concentrations of Phenylephrine in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2005-11","conditions":"Healthy","enrollment":97},{"nctId":"NCT01678313","phase":"PHASE2","title":"Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels","status":"COMPLETED","sponsor":"Buddhist Tzu Chi General Hospital","startDate":"2012-08","conditions":"Benign Prostatic Hyperplasia","enrollment":140},{"nctId":"NCT01661621","phase":"PHASE4","title":"Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1","status":"COMPLETED","sponsor":"Buddhist Tzu Chi General Hospital","startDate":"2012-08","conditions":"Bladder Outlet Obstruction","enrollment":395},{"nctId":"NCT00563901","phase":"","title":"Analyzing How Genetics May Affect Response to High Blood Pressure Medications","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2000-09","conditions":"Hypertension, Coronary Disease, Cerebrovascular Accident","enrollment":37939},{"nctId":"NCT00687388","phase":"PHASE4","title":"The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia","status":"WITHDRAWN","sponsor":"Samsung Medical Center","startDate":"2008-05","conditions":"Benign Prostatic Hyperplasia","enrollment":""},{"nctId":"NCT00130156","phase":"PHASE4","title":"Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2005-10","conditions":"High Blood Pressure","enrollment":93},{"nctId":"NCT00661895","phase":"PHASE4","title":"Black Education and Treatment of Hypertension (BEAT HTN)","status":"COMPLETED","sponsor":"Creighton University","startDate":"2005-08","conditions":"Hypertension","enrollment":99},{"nctId":"NCT01062945","phase":"PHASE1","title":"The Effects of Doxazosin on the Cardiovascular and Subjective Effects of Cocaine","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2010-01","conditions":"Cocaine Addiction, Cocaine Abuse, Cocaine Dependence","enrollment":13},{"nctId":"NCT00713739","phase":"PHASE3","title":"Alfuzosin for Medical Expulsion Therapy of Ureteral Stones","status":"UNKNOWN","sponsor":"United States Naval Medical Center, San Diego","startDate":"2008-01","conditions":"Kidney Stones","enrollment":240},{"nctId":"NCT00517179","phase":"NA","title":"Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITS","status":"COMPLETED","sponsor":"Hospital Authority, Hong Kong","startDate":"2006-04","conditions":"Prostatic Hyperplasia, Impotence","enrollment":40},{"nctId":"NCT00563485","phase":"NA","title":"Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up","status":"TERMINATED","sponsor":"Hospital Authority, Hong Kong","startDate":"2005-10","conditions":"Prostatic Hyperplasia, Urinary Retention","enrollment":120},{"nctId":"NCT01100021","phase":"PHASE1","title":"Hemodynamic Study of Avanafil and Two α-Adrenergic Blockers,Doxazosin and Tamsulosin","status":"COMPLETED","sponsor":"VIVUS LLC","startDate":"2010-02","conditions":"Erectile Dysfunction","enrollment":48},{"nctId":"NCT00730418","phase":"NA","title":"Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2007-01","conditions":"Benign Prostatic Hyperplasia","enrollment":25},{"nctId":"NCT00424801","phase":"NA","title":"Effects of Intensive Long-Term Vasodilation in Hypertensive Patients With Microvascular Angina Pectoris","status":"TERMINATED","sponsor":"University of Aarhus","startDate":"2007-01","conditions":"Microvascular Angina, Hypertension","enrollment":10},{"nctId":"NCT00295542","phase":"PHASE4","title":"Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy","status":"COMPLETED","sponsor":"University of Vigo","startDate":"2000-03","conditions":"Hypertension","enrollment":3344},{"nctId":"NCT00684489","phase":"NA","title":"Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2003-09","conditions":"Hypertension","enrollment":52},{"nctId":"NCT00295555","phase":"PHASE4","title":"Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy","status":"COMPLETED","sponsor":"Yokohama City University Medical Center","startDate":"2004-01","conditions":"Diabetes Mellitus, Essential Hypertension, Renal Failure","enrollment":98},{"nctId":"NCT00285519","phase":"PHASE4","title":"Japan Morning Surge-1 Study","status":"COMPLETED","sponsor":"Japan Heart Foundation","startDate":"2003-08","conditions":"Hypertension","enrollment":600}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":531,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Doxazosin (drug)","genericName":"Doxazosin (drug)","companyName":"Japan Heart Foundation","companyId":"japan-heart-foundation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Doxazosin is an alpha-1 adrenergic receptor antagonist that blocks norepinephrine signaling in blood vessels and the prostate, causing vasodilation and smooth muscle relaxation. Used for Hypertension, Benign prostatic hyperplasia with lower urinary tract symptoms.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}